[1]
M. Rewekant, “Role of Antipsychotic Agents in Dementia-Associated Neuropsychiatric Symptoms: Efficacy, Safety, and Deprescribing Strategies”, Qual Sport, vol. 61, p. 73181, Jul. 2026.